Abecma
CHMP backs J&J’s myeloma CAR-T therapy Carvykti
Phil Taylor
Abecma, BCMA Targeted Therapies, Bristol-Myers Squibb, CAR-T therapies, Carvykti, immuno-oncology, Johnson & Johnson, multiple myeloma, Oncology
0 Comment
X
CHMP backs J&J’s myeloma CAR-T therapy Carvykti
https://pharmaphorum.com/news/chmp-backs-jjs-myeloma-car-t-therapy-carvykti/
FDA sets November review date for J&J’s multiple myeloma CAR-T cilta-cel
Phil Taylor
Abecma, BCMA Targeted Therapies, bluebird bio, Bristol-Myers Squibb, CAR-T therapies, immuno-oncology, Johnson & Johnson, multiple myeloma, Oncology
0 Comment
X
FDA sets November review date for J&J’s multiple myeloma CAR-T cilta-cel
https://pharmaphorum.com/news/fda-sets-november-review-date-for-jjs-multiple-myeloma-car-t-cilta-cel/
FDA approves BMS’ multiple myeloma CAR-T Abecma
Richard Staines
Abecma, Bristol-Myers Squibb, CAR T, multiple myeloma
0 Comment
X
FDA approves BMS’ multiple myeloma CAR-T Abecma
https://pharmaphorum.com/news/fda-approves-bms-multiple-myeloma-car-t-abecma/